Clinical Trial Update: Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant PD-1 blockade plus chemotherapy for esophageal squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-1 blockade

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Esophageal Squamous Cell Carcinoma, Immunotherapy | Phase 2 | Status: COMPLETED